ST葫芦娃(605199.SH)：公司收到头孢地尼胶囊的《药品注册证书》

Core Viewpoint - ST HuLuWa (605199.SH) has received the drug registration certificate for Cefdinir capsules from the National Medical Products Administration, marking a significant milestone in its product development [1] Group 1: Product Development - Cefdinir is classified as a third-generation broad-spectrum cephalosporin antibiotic, effective against various infections sensitive to Cefdinir [1] - The company has invested a total of 4.4957 million yuan in the research and development of this product [1]